수의용 영상 시장 : 영상 진단법, 동물 유형, 컴포넌트, 최종 사용자, 판매 채널, 임상 용도별 예측(2026-2032년)

The Veterinary Imaging Market was valued at USD 2.33 billion in 2025 and is projected to grow to USD 2.49 billion in 2026, with a CAGR of 7.28%, reaching USD 3.81 billion by 2032.

An authoritative overview of how technological innovation and clinical demand are reshaping diagnostic pathways and procurement priorities across veterinary imaging

The veterinary imaging landscape is evolving rapidly as clinical demand and technological innovation intersect to create new diagnostic pathways for animal health. Advances in modalities such as computed tomography and magnetic resonance imaging are expanding veterinarians' ability to diagnose complex conditions across species, while refinements in ultrasound and digital radiography improve workflow efficiency and bedside decision-making. Concurrently, software capabilities-from three-dimensional reconstruction tools to integrated picture archiving and communication systems-are reshaping data management and diagnostic collaboration. Together, these developments are influencing procurement strategies, clinical protocols, and service delivery models in diagnostic laboratories, veterinary clinics, and hospitals.

Beyond technology, shifts in the types of animals receiving advanced imaging, from small companion animals to equine and select exotic species, are changing equipment utilization patterns. End users are adapting by consolidating imaging services in referral centers and by integrating portable and cart-based systems for on-site diagnostics. As stakeholders prioritize both diagnostic accuracy and operational efficiency, the convergence of hardware and software solutions becomes a central theme for clinical leaders, researchers, and enterprise decision-makers seeking to align capital investments with long-term care objectives.

How modality convergence, software-enabled workflows, portability, and evolving commercial models are collectively transforming veterinary imaging delivery

Adoption patterns and innovation trajectories within veterinary imaging are being redirected by several transformative shifts that span technology, clinical practice, and commercial models. First, modality convergence is becoming more pronounced: high-resolution imaging techniques such as multi-slice computed tomography are being paired with advanced post-processing software to produce diagnostic insights previously confined to specialty centers. Simultaneously, the migration of magnetic resonance imaging systems into lower-field, more compact footprints is widening access for clinics that historically could not accommodate large-field systems. These hardware adaptations are paralleled by software maturation, where workflow applications and cloud-enabled PACS reduce friction in image sharing and multidisciplinary case review.

Another significant shift is the decentralization of imaging services. Portable ultrasound and compact radiography units enable point-of-care diagnostics in ambulatory settings and on-site in large-animal environments, which shortens diagnostic timelines and reduces the need for patient transport. In parallel, endoscopy platforms are becoming more flexible and modular, improving procedural throughput and cross-specialty utilization. Lastly, commercial dynamics are evolving as vendors offer bundled hardware-software service contracts and flexible sales channels, including direct sales and distributor partnerships, to meet diverse procurement strategies across clinics, hospitals, and research institutes. These shifts are collectively driving a more integrated, accessible, and clinically responsive imaging ecosystem.

Why 2025 tariff dynamics are reshaping procurement choices, distribution strategies, and service models across veterinary imaging stakeholders in the United States

In 2025, the import tariffs imposed by the United States will continue to influence equipment sourcing, vendor strategies, and distribution pathways across the veterinary imaging sector. Tariff adjustments affect capital acquisition costs for high-value hardware such as CT and MRI systems, prompting some buyers to reassess the balance between purchasing new equipment and upgrading existing assets. As a result, stakeholders often pursue vendors with localized service capabilities or local distributor arrangements to mitigate supply chain risk and reduce total cost of ownership. Simultaneously, tariff pressures accentuate the appeal of portable and cart-based ultrasound and compact radiography systems, which typically involve lower logistics complexity and smaller duty burdens.

From a market behavior perspective, tariffs can accelerate diversification of procurement channels: end users increasingly evaluate global distributors and local partners to secure favorable delivery terms, spare parts availability, and maintenance agreements. Research institutes and diagnostic laboratories may prioritize supplier relationships that include comprehensive service-level agreements to preserve uptime despite customs-related uncertainties. Moreover, manufacturers and channel partners may respond by relocating production, deepening regional partnerships, or enhancing bundled service offerings to maintain competitiveness. Consequently, tariff dynamics in 2025 are a material consideration in capital planning and vendor selection, shaping decisions from budget allocations to clinical service expansion.

Detailed segmentation analysis revealing how modality features, animal-specific clinical needs, end-user priorities, and product-service mixes drive differentiated demand

A granular view of segmentation reveals differentiated demand drivers and clinical use-cases that influence product design, sales strategies, and service delivery. When examined by imaging modality, computed tomography retains prominence for complex musculoskeletal and oncologic cases, with multi-slice systems offering higher throughput for busy referral centers and single-slice units providing a lower-cost option for smaller facilities. Endoscopy's flexible and rigid variants serve distinct procedural needs: flexible endoscopes are optimized for soft-tissue and minimally invasive diagnostics, whereas rigid endoscopes support orthopedic and specialized interventions. Magnetic resonance imaging bifurcates into high-field and low-field solutions, where high-field systems deliver superior soft-tissue contrast for advanced neurology and oncology, while low-field systems offer affordability and simplified installation.

Animal-type segmentation underscores the diversity of clinical requirements: equine practice demands large-bore and mobile imaging configurations to accommodate size and field constraints, whereas small animal workflows emphasize speed, throughput, and high-resolution modalities for cats and dogs. Exotic species introduce unique instrumentation and anesthesia considerations, particularly for avian and reptile diagnostics. End-user segmentation clarifies where value is realized, as diagnostic laboratories and research institutes prioritize high-end modalities and software for advanced analysis, while veterinary clinics and hospitals focus on integrated systems that balance diagnostic capability with clinical throughput. Product-type distinctions between hardware systems and software suites highlight the growing importance of 3D imaging software, PACS, and workflow tools in extracting clinical value, and sales-channel segmentation differentiates procurement preferences, with direct sales often supporting bespoke configurations and distributor channels facilitating broader geographic reach.

Regional dynamics and infrastructure variability that determine how veterinary imaging technologies are adopted and serviced across global markets

Regional dynamics exert a powerful influence on technology adoption, regulatory environment, and service provision across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, clinical consolidation and a mature private-payer landscape foster investment in advanced modalities and integrated software platforms, particularly among referral hospitals and specialty diagnostic centers. Conversely, in Europe, Middle East & Africa, variability in healthcare funding and infrastructure leads to a dual market where high-end tertiary centers coexist with growing demand for portable and cost-efficient imaging in emergent and rural settings.

Asia-Pacific presents a mix of rapid adoption in urban referral centers and an expanding base of clinics seeking scalable imaging solutions, driven by rising pet ownership and expanded veterinary education. Across regions, distributor networks and local manufacturing footprints shape equipment availability and after-sales support, while regional training and certification programs influence clinical utilization patterns. As a result, strategic approaches to product rollout and service models must account for regional regulatory regimes, logistic complexity, and the differing pace at which clinics, hospitals, and research organizations adopt new imaging capabilities.

Competitive dynamics and strategic differentiators among manufacturers, software vendors, and distributor partners that shape procurement and lifecycle value

The competitive landscape in veterinary imaging is characterized by a mixture of established medical imaging manufacturers, specialized veterinary equipment providers, and software innovators that together shape product roadmaps and customer expectations. Market participants are differentiating through investments in modality-specific advancements, enhanced service agreements, and expanded training programs aimed at improving clinical outcomes and system utilization. Vendors that integrate comprehensive software ecosystems-encompassing 3D visualization, PACS, and workflow automation-tend to strengthen client retention by simplifying case management and facilitating teleconsultation.

In addition, partnerships between equipment makers and local distributors or clinical networks enhance market access and reduce adoption friction, particularly in regions where installation and maintenance logistics are complex. Companies pursuing modular hardware designs and field-upgradable software features are better positioned to address diverse end-user needs across small animal clinics, large-animal practices, and research institutes. Finally, emphasis on lifecycle support, including spare-parts availability, remote diagnostics, and training resources, increasingly factors into procurement decisions, favoring suppliers that can demonstrate reliable long-term service delivery and clinical education offerings.

Actionable strategic moves for manufacturers, distributors, and clinical buyers to align product, service, and procurement models with evolving diagnostic needs

Industry leaders should adopt an integrated approach that aligns product portfolios, sales channels, and service models with evolving clinical workflows and regional realities. To begin, prioritizing modularity in hardware design and cloud-enabled software will increase adaptability across diverse clinical environments, enabling vendors to address both high-throughput referral centers and smaller ambulatory clinics. Vendors should also strengthen distributor partnerships and local service networks to mitigate tariff-related supply chain risks and to assure timely maintenance and parts support, particularly in regions with complex logistics.

Clinicians and institutional buyers should focus on total operational value rather than upfront cost alone, assessing how workflow software, PACS integration, and training programs enhance throughput and diagnostic confidence. Research institutes and diagnostic laboratories would benefit from collaborating with manufacturers on pilot deployments that validate modality performance for specific species and clinical indications. Finally, purchasers across regions should negotiate service-level agreements that include remote support, upgrading pathways, and access to analytics that track utilization-thereby ensuring that imaging assets continue to deliver clinical and economic value over their operational life.

A transparent, multi-method research approach combining practitioner interviews, technical validation, and supply-chain assessment to underpin findings and insights

The research synthesized here is grounded in a multi-method approach combining primary and secondary data collection with rigorous analytical protocols to ensure transparent, reproducible insights. Primary inputs consisted of structured interviews and consultations with practicing veterinarians, clinical directors, imaging technicians, procurement officers, and distributor representatives to capture real-world decision drivers, usage patterns, and service expectations. These qualitative inputs were augmented by device-level technical specifications, regulatory guidance, and product literature to validate performance characteristics and deployment constraints.

Analytical steps included cross-validation of clinical use-cases with end-user feedback, mapping product capabilities to animal-type and facility-level requirements, and assessing sales-channel implications for installation and lifecycle support. Where applicable, supply chain and tariff impacts were evaluated through logistics assessments and distributor interviews to identify sourcing sensitivities. Throughout the methodology, care was taken to protect respondent confidentiality, triangulate findings across multiple data sources, and document assumptions that informed interpretive analysis and sectoral implications.

A synthesis of how modality evolution, software integration, regional variability, and procurement dynamics will determine clinical value and operational success

In conclusion, veterinary imaging is at an inflection point where technological advances, shifting clinical demand across species, and changing commercial dynamics intersect to redefine diagnostic pathways. The increasing sophistication of computed tomography and magnetic resonance technologies, together with the rise of portable ultrasound and digital radiography, offers clinicians more diagnostic options and improves the timeliness of care. At the same time, software ecosystems including 3D imaging tools and PACS are emerging as essential enablers of workflow efficiency, remote consultation, and longitudinal case management.

As stakeholders navigate tariff uncertainties, regional infrastructure differences, and diverse end-user needs, success will favor organizations that prioritize modularity, service excellence, and strong distributor relationships. Clinicians should seek integrated solutions that align modality capability with species-specific requirements and clinical throughput, while vendors must focus on delivering quantifiable operational value and robust after-sales support. These combined efforts will help ensure that imaging investments translate into better diagnostics, more efficient clinical workflows, and improved outcomes across small animal, large animal, equine, and exotic practice settings.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Imaging Market, by Imaging Modality

• 8.1. Computed Tomography
• 8.2. Endoscopy
  • 8.2.1. Flexible
  • 8.2.2. Rigid
• 8.3. Magnetic Resonance Imaging
• 8.4. Nuclear Imaging
• 8.5. Ultrasound
  • 8.5.1. Cart Based
  • 8.5.2. Portable
• 8.6. X Ray
  • 8.6.1. Computed Radiography
  • 8.6.2. Digital Radiography

9. Veterinary Imaging Market, by Animal Type

• 9.1. Exotic
  • 9.1.1. Avian
  • 9.1.2. Reptile
• 9.2. Large Animal & Equine
  • 9.2.1. Cattle
  • 9.2.2. Swine
  • 9.2.3. Horse
• 9.3. Small Animal
  • 9.3.1. Cat
  • 9.3.2. Dog

10. Veterinary Imaging Market, by Component

• 10.1. Hardware
• 10.2. Software
• 10.3. Services
• 10.4. Consumables

11. Veterinary Imaging Market, by End User

• 11.1. Diagnostic Laboratory
• 11.2. Research Institute
• 11.3. Veterinary Clinic & Hospital

12. Veterinary Imaging Market, by Sales Channel

• 12.1. Direct Sales
• 12.2. Distributor Sales
• 12.3. Online

13. Veterinary Imaging Market, by Clinical Application

• 13.1. Orthopedic & Musculoskeletal
• 13.2. Cardiology
• 13.3. Emergency And Critical Care
• 13.4. Respiratory & Thoracic
• 13.5. Dentistry
• 13.6. Abdominal
• 13.7. Neurology
• 13.8. Oncology

14. Veterinary Imaging Market, by Region

• 14.1. Americas
  • 14.1.1. North America
  • 14.1.2. Latin America
• 14.2. Europe, Middle East & Africa
  • 14.2.1. Europe
  • 14.2.2. Middle East
  • 14.2.3. Africa
• 14.3. Asia-Pacific

15. Veterinary Imaging Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Veterinary Imaging Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. United States Veterinary Imaging Market

18. China Veterinary Imaging Market

19. Competitive Landscape

• 19.1. Market Concentration Analysis, 2025
  • 19.1.1. Concentration Ratio (CR)
  • 19.1.2. Herfindahl Hirschman Index (HHI)
• 19.2. Recent Developments & Impact Analysis, 2025
• 19.3. Product Portfolio Analysis, 2025
• 19.4. Benchmarking Analysis, 2025
• 19.5. IDEXX Laboratories, Inc.
• 19.6. GE Healthcare
• 19.7. Canon Inc.
• 19.8. Fujifilm Holdings Corporation
• 19.9. Siemens Healthineers
• 19.10. Esaote S.p.A.
• 19.11. Carestream Health, Inc.
• 19.12. Shimadzu Corporation
• 19.13. Agfa-Gevaert Group
• 19.14. BioChek B.V.
• 19.15. BMV MEDTECH GROUP CO., LTD.
• 19.16. Chison Medical Technologies Co., Ltd.
• 19.17. Clarius Mobile Health Corp.
• 19.18. Covetrus, Inc.
• 19.19. DRAMINSKI S. A.
• 19.20. E.I. Medical Imaging
• 19.21. Edan Instruments, Inc.
• 19.22. Epica Medical Innovations Inc.
• 19.23. Hallmarq Veterinary Imaging
• 19.24. Heska Corporation by Mars, Incorporated
• 19.25. IM3 Inc.
• 19.26. IMV Imaging (UK) Ltd.
• 19.27. Interson Corporation
• 19.28. Leltek Inc.
• 19.29. Lepu Medical Technology (Beijing) Co., Ltd.
• 19.30. Merck KGaA
• 19.31. MinXray, Inc.
• 19.32. Narang Medical Limited
• 19.33. Probo Medical
• 19.34. Promed Technology Co., Ltd.
• 19.35. ReproScan
• 19.36. Samsung Electronics Co., Ltd.
• 19.37. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 19.38. SonoScape Medical Corp.
• 19.39. Thermo Fisher Scientific, Inc.
• 19.40. Vet Rocket, Inc.
• 19.41. Zoetis, Inc.